Table 1 Baseline characteristics of study patients
Variable | DAPT group (n = 168) | Argatroban group (n = 136) | P Value |
|---|---|---|---|
Demographics | |||
 Age, mean (SD), y | 62 ± 7.8 | 63 ± 6.4 | 0.17 |
 Male, no. (%) | 96(57.1) | 73 (59.3) | 0.34 |
Medical history | |||
 Hypertension, no. (%) | 91(54.1) | 71(52.2) | 0.73 |
 Diabetes mellitus, no. (%) | 86(51.1) | 76(55.8) | 0.41 |
 Hyperlipidemia, no. (%) | 93(55.3) | 65(47.7) | 0.88 |
 Current smoker, no. (%) | 70(41.6) | 62(45.5) | 0.49 |
 History of stroke, no. (%) | 22(13.0) | 20(14.7) | 0.62 |
 History of coronary artery disease, no. (%) | 65(38.6) | 47(34.5) | 0.45 |
Laboratory measures | |||
 Glucose, mean (SD), mmol/L | 7.2 (2.6) | 7.4 (3.1) | 0.61 |
 Hematocrit, mean (SD) | 0.41(0.16) | 0.43(0.24) | 0.68 |
 Fibrinogen, mean (SD), g/l | 4.3(1.5) | 4.0(1.0) | 0.44 |
 WBC count, mean (SD), 109/L | 7.6(2.5) | 7.8(2.2) | 0.63 |
 BUN, mean (SD), mmol/L | 4.6(1.4) | 4.7(1.6) | 0.72 |
 Cr, mean (SD), mmol/L | 66(8.2) | 64(6.4) | 0.63 |
Clinical characteristics | |||
 SBP, Median (IQR), mmHg | 159 (125–168) | 140 (121–151) | 0.03 |
 Initial diameter, mean (SD), mm | 17.6 ± 2.1 | 17.8 ± 2.1 | 0.29 |
 Presence of microbleeds, no. (%) | 20(11.9) | 16(13.0) | 0.59 |
 Plaques in superior side, no. (%) | 25/46(54.3) | 20/32(62.5) | 0.49 |
 Baseline NIHSS score, Median (IQR) | 4 (3–7) | 4 (3–6) | 0.47 |
Medicine | |||
 Stain, no. (%) | 21(12.5) | 19(13.9) | 0.82 |
 Antihypertensive, no. (%) | 87(51.8) | 59(43.4) | 0.56 |